These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP, Kokeny KE, Ridings JW, Dilts CA. Cancer Res; 1996 Feb 15; 56(4):899-907. PubMed ID: 8631031 [Abstract] [Full Text] [Related]
7. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC. Cancer Res; 1991 Oct 01; 51(19):5361-9. PubMed ID: 1680547 [Abstract] [Full Text] [Related]
8. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells. Shawver LK, Mann E, Elliger SS, Dugger TC, Arteaga CL. Cancer Res; 1994 Mar 01; 54(5):1367-73. PubMed ID: 7907001 [Abstract] [Full Text] [Related]
9. Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation. Meenakshi A, Kumar RS, Kumar NS. Hum Antibodies; 2001 Mar 01; 10(3-4):101-7. PubMed ID: 11847421 [Abstract] [Full Text] [Related]
11. Reduced expression of c-erbB2 gene product in human mammary carcinoma SK-BR-3 cells treated with interferon-gamma and tumor necrosis factor-alpha. Kumar R, Mendelsohn J. Anticancer Res; 1994 Mar 01; 14(3A):1001-8. PubMed ID: 7915505 [Abstract] [Full Text] [Related]
12. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues. Lee H, Maihle NJ. Oncogene; 1998 Jun 25; 16(25):3243-52. PubMed ID: 9681822 [Abstract] [Full Text] [Related]
14. p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ. Cancer Res; 1994 Jul 15; 54(14):3758-65. PubMed ID: 7913407 [Abstract] [Full Text] [Related]
16. An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene. Langton BC, Crenshaw MC, Chao LA, Stuart SG, Akita RW, Jackson JE. Cancer Res; 1991 May 15; 51(10):2593-8. PubMed ID: 1673637 [Abstract] [Full Text] [Related]
17. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. Pupa SM, Ménard S, Morelli D, Pozzi B, De Palo G, Colnaghi MI. Oncogene; 1993 Nov 15; 8(11):2917-23. PubMed ID: 8105438 [Abstract] [Full Text] [Related]
18. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Brysch W, Magal E, Louis JC, Kunst M, Klinger I, Schlingensiepen R, Schlingensiepen KH. Cancer Gene Ther; 1994 Jun 15; 1(2):99-105. PubMed ID: 7621247 [Abstract] [Full Text] [Related]
19. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry. Li BD, Bauer KD, Carney WP, Duda RB. J Surg Res; 1993 Mar 15; 54(3):179-88. PubMed ID: 7682635 [Abstract] [Full Text] [Related]
20. Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. DiGiovanna MP, Stern DF. Cancer Res; 1995 May 01; 55(9):1946-55. PubMed ID: 7728765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]